Regenerative medicines are used to repair, replace, and regenerate tissues and organs affected by injury, disease, or natural aging process. These medicines restore the functionality of cells & tissues and are used in several degenerative disorders such as dermatology, neurodegenerative diseases, cardiovascular, and orthopedic applications. Stem cells are capable of proliferation and differentiation, which increase their importance in this field. The factors driving the growth of this market include emergence of stem cell technology, untapped potential of nanotechnology, increase in prevalence of chronic diseases & trauma emergencies, advancement in monitoring devices and surgical technologies, rise in incidence of degenerative diseases, and shortage of organs for transplantation. Increase in focus on stem cells and growth in R&D activities in emerging economies are expected to supplement the market growth. The developing nations are focused on technological advancements, which is expected to boost the market growth, globally. However, stringent government regulations, operational inefficiency, and high cost of treatment through regenerative medicine are estimated to hamper the growth of the market. In 2018, the global Regenerative Medicine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Regenerative Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Regenerative Medicine development in United States, Europe and China. The key players covered in this study Stryker Corporation Zimmer Biomet Holdings Medtronic Plc. Athersys, Inc. U.S. Stem Cell, Inc. (Bioheart, Inc.) Organogenesis, Inc. (Advanced Biohealing) Integra Lifesciences Holdings Corporation Acelity Holdings Isto Biologics (Isto Biologics Medical Systems, Inc.) CryoLife Shimadzu Recursion Pharmaceuticals Baxter International DePuy Synthes Siemens Healthineers General Electric (GE) Company Koninklijke Philips N.V. Cloudmedx Bay Labs Market segment by Type, the product can be split into Cell Therapy Gene Therapy Tissue Engineering Small Molecule & Biologic Market segment by Application, split into Cardiovascular Oncology Dermatology Musculoskeletal Wound Healing Ophthalmology Neurology Others Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Regenerative Medicine status, future forecast, growth opportunity, key market and key players. To present the Regenerative Medicine development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Regenerative Medicine are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Regenerative Medicine Market Size Growth Rate by Type (2014-2025) 1.4.2 Cell Therapy 1.4.3 Gene Therapy 1.4.4 Tissue Engineering 1.4.5 Small Molecule & Biologic 1.5 Market by Application
